8-K Announcements
6Material company update
Apr 30, 2026·SEC
Material company update
Feb 11, 2026·SEC
Material company update
Feb 5, 2026·SEC
CNO Financial Group, Inc.(CNO)Earnings, Financials & Key Ratios
CNO•NYSE•Insurance & Managed Care
21.6× P/E·Price updated Jun 19, 2026
SectorFinancial ServicesIndustryLife InsuranceSub-IndustryIndividual life and final expense insurers
AboutCNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, and other insurance products for senior and middle-income markets in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individuals through phone, online, mail, and face-to-face. The company also focuses on worksite and group sales for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed index annuities; fixed interest annuities, including fixed rate single and flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. CNO Financial Group, Inc. markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company sells its products through agents, independent producers, and direct marketing. CNO Financial Group, Inc. was founded in 1979 and is headquartered in Carmel, Indiana.Show more
- Revenue$4.49B+0.9%
- Combined Ratio93.46%+5.8%
- Net Income$229M-43.2%
- Return on Equity8.9%-47.9%
- Medical Cost Ratio55.21%-10.5%
- Operating Margin6.54%-43.9%
- Net Margin5.11%-43.8%
- ROA0.6%-46.0%
- Equity / Assets6.8%+2.3%
CNO Key Insights
CNO Financial Group, Inc. (CNO) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Profitable underwriting: 93.5% combined ratio
- ✓14 consecutive years of dividend growth
- ✓Low loss ratio of 55.2%
- ✓Share count reduced 9.6% through buybacks
- ✓Trading near 52-week high
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when CNO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CNO Price & Volume
CNO Financial Group, Inc. (CNO) stock price & volume — 10-year historical chart
Loading chart...
CNO Growth Metrics
CNO Financial Group, Inc. (CNO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years1.68%
5 Years3.27%
3 Years7.85%
TTM0.94%
Profit CAGR
10 Years-1.65%
5 Years-5.35%
3 Years-28.62%
TTM-45.17%
EPS CAGR
10 Years5.39%
5 Years2.18%
3 Years-24.03%
TTM-40.89%
Return on Capital
10 Years1.86%
5 Years2.08%
3 Years1.77%
Last Year1.48%
CNO Recent Earnings
CNO Financial Group, Inc. (CNO) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 12/12 qtrs (100%)
Q2 2026Latest
Apr 30, 2026Metric
Actual
Est
EPS
$1.29+41.8%
$0.91
Rev
$1.0B+2.6%
$1.0B
Q1 2026
Feb 5, 2026Metric
Actual
Est
EPS
$1.47+22.5%
$1.20
Rev
$1.1B+13.9%
$1.0B
Q4 2025
Nov 3, 2025Metric
Actual
Est
EPS
$0.96-20.7%
$1.21
Rev
$1.2B+18.5%
$1.0B
Q3 2025
Jul 28, 2025Metric
Actual
Est
EPS
$0.87+2.4%
$0.85
Rev
$1.2B+18.1%
$975M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $1.29vs $0.91+41.8% | $1.0Bvs $1.0B+2.6% |
| Q1 2026 | Feb 5, 2026 | $1.47vs $1.20+22.5% | $1.1Bvs $1.0B+13.9% |
| Q4 2025 | Nov 3, 2025 | $0.96vs $1.21-20.7% | $1.2Bvs $1.0B+18.5% |
| Q3 2025 | Jul 28, 2025 | $0.87vs $0.85+2.4% | $1.2Bvs $975M+18.1% |
Based on last 12 quarters of dataView full earnings history →
CNO Peer Comparison
CNO Financial Group, Inc. (CNO) competitors in Individual life and final expense insurers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 GL | 13.4B | 170.76 | 12.15 | 3.82% | 19.36% | 20.64% | 0.44 | |
 FG | 3.73B | 27.49 | 14.62 | 5.72% | 9.11% | 11.15% | 0.45 | |
 CRBG | 13.33B | 29.18 | -42.91 | 7.88% | 3.94% | 1.85% | 0.78 | |
 PFG | 23.74B | 109.57 | 20.87 | -3.11% | 7.58% | 9.89% | 0.34 | |
 LNC | 7.11B | 37.17 | 6.36 | 1.24% | 9.14% | 16.79% | 0.59 | |
 RLI | 4.88B | 53.09 | 12.18 | 6.33% | 20.8% | 22% | 0.06 | |
 MET | 55.8B | 85.58 | 17.83 | 10.22% | 4.7% | 12.72% | 0.70 | |
 PRU | 37.05B | 106.53 | 10.42 | -14.01% | 5.62% | 10.26% | 0.65 |
Compare CNO vs Peers
CNO Financial Group, Inc. (CNO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CNO Income Statement
CNO Financial Group, Inc. (CNO) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.3B | 4.31B | 4.02B | 3.82B | 4.12B | 3.58B | 4.15B | 4.45B | 4.49B |
Revenue Growth % | 7.74% | 0.28% | -6.9% | -4.85% | 7.88% | -13.23% | 15.94% | 7.21% | 0.94% |
Medical Costs & Claims | 2.96B | 3.73B | 2.78B | 2.54B | 2.42B | 1.79B | 2.61B | 2.74B | 2.48B |
Medical Cost Ratio % | 68.76% | 86.55% | 69.29% | 66.42% | 58.77% | 49.95% | 63.04% | 61.71% | 55.21% |
Gross Profit | 1.34B▲ 0% | 580.2M▼ 56.8% | 1.23B▲ 112.5% | 1.28B▲ 4.1% | 1.7B▲ 32.4% | 1.79B▲ 5.3% | 1.53B▼ 14.4% | 1.7B▲ 11.1% | 2.01B▲ 18.1% |
Gross Margin % | 31.24% | 13.45% | 30.71% | 33.58% | 41.23% | 50.05% | 36.96% | 38.29% | 44.79% |
Gross Profit Growth % | 15.58% | -56.83% | 112.53% | 4.07% | 32.42% | 5.34% | -14.39% | 11.07% | 18.07% |
Operating Expenses | 863.4M | 845M | 958.9M | 939M | 966.3M | 973.7M | 1.18B | 1.18B | 1.72B |
OpEx / Revenue % | 20.07% | 19.59% | 23.88% | 24.57% | 23.44% | 27.22% | 28.35% | 26.63% | 38.25% |
Depreciation & Amortization | 265.4M | 292.2M | 267.9M | 303.9M | 236.6M | 248.5M | 267.4M | 292.4M | 0 |
Combined Ratio % | 88.83% | 106.14% | 93.17% | 90.99% | 82.22% | 77.17% | 91.4% | 88.34% | 93.46% |
Operating Income | 480.5M▲ 0% | -264.8M▼ 155.1% | 274.2M▲ 203.5% | 344.3M▲ 25.6% | 733.1M▲ 112.9% | 816.5M▲ 11.4% | 356.8M▼ 56.3% | 518.3M▲ 45.3% | 293.4M▼ 43.4% |
Operating Margin % | 11.17% | -6.14% | 6.83% | 9.01% | 17.78% | 22.83% | 8.6% | 11.66% | 6.54% |
Operating Income Growth % | 36.04% | -155.11% | 203.55% | 25.57% | 112.92% | 11.38% | -56.3% | 45.26% | -43.39% |
EBITDA | 745.9M | 27.4M | 542.1M | 648.2M | 969.7M | 1.06B | 624.2M | 810.7M | 524.3M |
EBITDA Margin % | 17.34% | 0.64% | 13.5% | 16.96% | 23.52% | 29.78% | 15.05% | 18.24% | 11.68% |
Interest Expense | 123.7M | 149.8M | 152.3M | 108.8M | 95.4M | 137M | 238.6M | 254.4M | 230.9M |
Non-Operating Income | -123.7M | -149.8M | -152.3M | -108.8M | -95.4M | -137M | -238.6M | -254.4M | -230.9M |
Pretax Income | 480.5M▲ 0% | -264.8M▼ 155.1% | 274.2M▲ 203.5% | 344.3M▲ 25.6% | 733.1M▲ 112.9% | 816.5M▲ 11.4% | 356.8M▼ 56.3% | 518.3M▲ 45.3% | 293.4M▼ 43.4% |
Pretax Margin % | 11.17% | -6.14% | 6.83% | 9.01% | 17.78% | 22.83% | 8.6% | 11.66% | 6.54% |
Income Tax | 304.9M | 50.2M | -135.2M | 42.5M | 162.8M | 185.9M | 80.3M | 114.3M | 64.1M |
Effective Tax Rate % | 63.45% | -18.96% | -49.31% | 12.34% | 22.21% | 22.77% | 22.51% | 22.05% | 21.85% |
Net Income | 175.6M▲ 0% | -315M▼ 279.4% | 409.4M▲ 230.0% | 301.8M▼ 26.3% | 570.3M▲ 89.0% | 630.6M▲ 10.6% | 276.5M▼ 56.2% | 404M▲ 46.1% | 229.3M▼ 43.2% |
Net Margin % | 4.08% | -7.3% | 10.19% | 7.9% | 13.83% | 17.63% | 6.67% | 9.09% | 5.11% |
Net Income Growth % | -50.98% | -279.38% | 229.97% | -26.28% | 88.97% | 10.57% | -56.15% | 46.11% | -43.24% |
EPS (Diluted) | 1.02▲ 0% | -1.90▼ 286.3% | 2.61▲ 237.4% | 2.11▼ 19.2% | 3.36▲ 59.2% | 5.36▲ 59.5% | 2.40▼ 55.2% | 3.74▲ 55.8% | 2.35▼ 37.2% |
EPS Growth % | -49.25% | -286.27% | 237.37% | -19.16% | 59.24% | 59.52% | -55.22% | 55.83% | -37.17% |
EPS (Basic) | 1.03 | -1.90 | 2.62 | 2.12 | 3.43 | 5.45 | 2.44 | 3.81 | 2.35 |
Diluted Shares Outstanding | 172.14M | 165.46M | 157.15M | 143.16M | 131.13M | 117.72M | 115.12M | 108.12M | 97.76M |
CNO Balance Sheet
CNO Financial Group, Inc. (CNO) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
Total Assets | 33.11B | 31.44B | 33.63B | 35.34B | 36.2B | 33.13B | 35.03B | 37.85B | 38.79B |
Asset Growth % | 3.55% | -5.05% | 6.97% | 5.08% | 2.45% | -8.48% | 5.72% | 8.06% | 2.49% |
Total Investment Assets | 27.85B | 23B | 25.58B | 27.58B | 51.17B | 24.34B | 768.6M | 27.87B | 30B |
Long-Term Investments | 25.23B | 20.44B | 22.77B | 24.96B | 26.36B | 3.78B | -20.74B | 4.84B | 22.08B |
Short-Term Investments | 22.91B | 18.45B | 21.3B | 23.38B | 24.81B | 20.56B | 21.51B | 23.03B | 7.92B |
Total Current Assets | 578M | 594M | 0 | 0 | 29.38B | 26.73B | 0 | 29.99B | 13.58B |
Cash & Equivalents | 178.9M | 62.4M | 74.7M | 54.1M | 99.6M | 69.2M | 774.5M | 1.66B | 956.1M |
Receivables | 0 | 0 | 5.22B | 4.78B | 4.47B | 5.52B | 4.98B | 4.96B | 4.68B |
Other Current Assets | 0 | 0 | -26.59B | -28.22B | 0 | 575.7M | -27.26B | 341M | 27.4M |
Goodwill & Intangibles | 1.39B | 1.67B | 0 | 0 | 1.33B | 1.97B | 2.13B | 2.32B | 2.54B |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 1.39B | 1.67B | 0 | 0 | 1.33B | 1.97B | 2.13B | 2.32B | 2.54B |
PP&E (Net) | -1.39B | -2.7B | 0 | 0 | 48.2M | 0 | 85.3M | 0 | 0 |
Other Assets | -20.56B | -12.86B | -22.77B | -24.96B | -1.38B | 648.8M | 52.42B | 703.2M | 590.9M |
Total Liabilities | 28.26B | 28.07B | 28.95B | 29.86B | 30.94B | 31.36B | 32.81B | 35.33B | 36.15B |
Total Debt | 3.97B | 3.98B | 3.79B | 3.93B | 4B | 3.88B | 4.15B | 4.52B | 4.05B |
Net Debt | 3.79B | 3.92B | 3.71B | 3.88B | 3.9B | 3.81B | 3.38B | 2.86B | 3.1B |
Long-Term Debt | 3.97B | 3.98B | 3.79B | 3.93B | 4B | 3.88B | 4.15B | 4.52B | 4.05B |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 24.29B | 24.09B | 0 | 0 | 8.4M | 15.47B | 0 | 17.82B | 19.14B |
Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 235M | 0 | 226.8M | 228M |
Other Current Liabilities | 24.29B | 24.09B | 0 | 0 | 8.4M | 15.23B | 0 | 17.59B | 18.91B |
Deferred Taxes | 1000K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Liabilities | 0 | 0 | -3.79B | -3.93B | 0 | 12.01B | 28.66B | 12.99B | 12.96B |
Total Equity | 4.85B▲ 0% | 3.37B▼ 30.5% | 4.68B▲ 38.7% | 5.48B▲ 17.3% | 5.26B▼ 4.1% | 1.77B▼ 66.4% | 2.22B▲ 25.3% | 2.52B▲ 13.5% | 2.64B▲ 4.9% |
Equity Growth % | 8.04% | -30.46% | 38.75% | 17.26% | -4.09% | -66.37% | 25.26% | 13.52% | 4.89% |
Shareholders Equity | 4.85B | 3.37B | 4.68B | 5.48B | 5.26B | 1.77B | 2.22B | 2.52B | 2.64B |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | 765.8M | 196.6M | 535.7M | 752.3M | 1.13B | 1.69B | 1.9B | 2.25B | 2.42B |
Common Stock | 1.7M | 1.6M | 1.5M | 1.3M | 1.2M | 1.1M | 1.1M | 1M | 900K |
Accumulated OCI | 1.01B | 177.7M | 1.37B | 2.19B | 1.95B | -1.96B | -1.58B | -1.37B | -1.11B |
Return on Equity (ROE) | 3.76% | -7.67% | 10.17% | 5.94% | 10.62% | 17.94% | 13.88% | 17.08% | 8.9% |
Return on Assets (ROA) | 0.54% | -0.98% | 1.26% | 0.88% | 1.59% | 1.82% | 0.81% | 1.11% | 0.6% |
Equity / Assets | 14.64% | 10.72% | 13.91% | 15.52% | 14.53% | 5.34% | 6.33% | 6.65% | 6.8% |
Debt / Equity | 0.82x | 1.18x | 0.81x | 0.72x | 0.76x | 2.20x | 1.87x | 1.80x | 1.54x |
Book Value per Share | 28.16 | 20.37 | 29.76 | 38.31 | 40.11 | 15.03 | 19.25 | 23.26 | 26.99 |
Tangible BV per Share | 20.11 | 10.30 | 29.76 | 38.31 | 29.93 | -1.75 | 0.79 | 1.81 | 1.00 |
CNO Cash Flow Statement
CNO Financial Group, Inc. (CNO) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 613.1M | 317.8M | 696.7M | 735.5M | 598.3M | 495.4M | 582.9M | 627.7M | 675.7M |
Operating CF Growth % | -19.28% | -48.17% | 119.23% | 5.57% | -18.65% | -17.2% | 17.66% | 7.69% | 7.65% |
Operating CF / Revenue % | 14.25% | 7.37% | 17.35% | 19.25% | 14.51% | 13.85% | 14.06% | 14.12% | 15.06% |
Net Income | 175.6M | -315M | 278M | 301.8M | 570.3M | 630.6M | 276.5M | 404M | 229.3M |
Depreciation & Amortization | 265.4M | 292.2M | 267.9M | 303.9M | 236.6M | 248.5M | 267.4M | 292.4M | 318.5M |
Stock-Based Compensation | 21.4M | 24.7M | 18.8M | 0 | 25.2M | 0 | 0 | 0 | 0 |
Deferred Taxes | 227.5M | 18.4M | -132.8M | 14.1M | 146.5M | 152M | 21.1M | 59.1M | 0 |
Other Non-Cash Items | -233.7M | 728.2M | -367.6M | -281.9M | -726.5M | -161M | -431.8M | -684.1M | -490.2M |
Working Capital Changes | 464.7M | 207.8M | 632.4M | 397.6M | 346.2M | -374.7M | 449.7M | 556.3M | 618.1M |
Cash from Investing | -239.6M | -525.7M | -555.6M | -608.4M | -1.53B | -1.78B | -872.3M | -1.49B | -1.67B |
Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Purchase of Investments | -6.14B | -6.21B | -5.59B | -4.28B | -6.15B | -6.52B | -3.62B | -6.89B | -8.46B |
Sale/Maturity of Investments | 5.92B | 5.71B | 5.14B | 3.71B | 4.7B | 4.8B | 2.79B | 5.42B | 6.8B |
Other Investing | -19.5M | -25M | -102M | -39.8M | -75.3M | -61.2M | -36.6M | -13.5M | -3.2M |
Cash from Financing | -274M | 107.2M | -143M | 210.1M | 667.6M | 1.2B | 533.5M | 1.97B | -22.6M |
Dividends Paid | -59.6M | -64.8M | -67.1M | -67M | -65.7M | -64.8M | -68.1M | -67.7M | -66.2M |
Share Repurchases | -168.3M | -108M | -254.5M | -268.3M | -407.8M | -190.1M | -166.1M | -300.2M | -331.4M |
Stock Issued | 8.3M | 3.9M | 9.2M | 19M | 21.5M | 13.5M | 13.2M | 11.2M | 11.6M |
Debt Issuance (Net) | -1000K | -100K | -1000K | 1000K | 1000K | -1000K | 1000K | 1000K | -1000K |
Other Financing | 213.3M | 276.2M | 379.2M | 384.5M | 1.05B | 1.56B | 495.8M | 1.96B | 833M |
Net Change in Cash | 99.5M▲ 0% | -100.7M▼ 201.2% | -1.9M▲ 98.1% | 337.2M▲ 17847.4% | -260.2M▼ 177.2% | -86.8M▲ 66.6% | 244.1M▲ 381.2% | 1.11B▲ 354.2% | -1.01B▼ 191.5% |
Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash at Beginning | 478.9M | 757.3M | 656.6M | 654.7M | 991.9M | 731.7M | 644.9M | 889M | 2B |
Cash at End | 578.4M | 656.6M | 654.7M | 991.9M | 731.7M | 644.9M | 889M | 2B | 983.5M |
Free Cash Flow | 613.1M▲ 0% | 317.8M▼ 48.2% | 696.7M▲ 119.2% | 735.5M▲ 5.6% | 598.3M▼ 18.7% | 495.4M▼ 17.2% | 582.9M▲ 17.7% | 627.7M▲ 7.7% | 675.7M▲ 7.6% |
FCF Growth % | -19.28% | -48.17% | 119.23% | 5.57% | -18.65% | -17.2% | 17.66% | 7.69% | 7.65% |
FCF Margin % | 14.25% | 7.37% | 17.35% | 19.25% | 14.51% | 13.85% | 14.06% | 14.12% | 15.06% |
FCF per Share | 3.56 | 1.92 | 4.43 | 5.14 | 4.56 | 4.21 | 5.06 | 5.81 | 6.91 |
CNO Key Ratios
CNO Financial Group, Inc. (CNO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Combined Ratio | 91.15% | 88.83% | 106.14% | 93.17% | 90.99% | 82.22% | 77.17% | 91.4% | 88.34% | 93.46% |
Medical Cost Ratio | 70.88% | 68.76% | 86.55% | 69.29% | 66.42% | 58.77% | 49.95% | 63.04% | 61.71% | 55.21% |
Return on Equity (ROE) | 8.31% | 3.76% | -7.67% | 10.17% | 5.94% | 10.62% | 17.94% | 13.88% | 17.08% | 8.9% |
Return on Assets (ROA) | 1.14% | 0.54% | -0.98% | 1.26% | 0.88% | 1.59% | 1.82% | 0.81% | 1.11% | 0.6% |
Equity / Assets | 14.03% | 14.64% | 10.72% | 13.91% | 15.52% | 14.53% | 5.34% | 6.33% | 6.65% | 6.8% |
Book Value / Share | 25.16 | 28.16 | 20.37 | 29.76 | 38.31 | 40.11 | 15.03 | 19.25 | 23.26 | 26.99 |
Debt / Equity | 0.94x | 0.82x | 1.18x | 0.81x | 0.72x | 0.76x | 2.20x | 1.87x | 1.80x | 1.54x |
Revenue Growth | 5.05% | 7.74% | 0.28% | -6.9% | -4.85% | 7.88% | -13.23% | 15.94% | 7.21% | 0.94% |
Related:CNO Dividend History·CNO Revenue History·CNO Price History·CNO P/E History·CNO Financial Ratios·CNO Institutional Holders
CNO SEC Filings & Documents
CNO Financial Group, Inc. (CNO) SEC filings — annual & quarterly reports (10-K, 10-Q)
CNO Frequently Asked Questions
CNO Financial Group, Inc. (CNO) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
CNO Financial Group, Inc. (CNO) grew revenue by 0.9% over the past year. Growth has been modest.
Yes, CNO Financial Group, Inc. (CNO) is profitable, generating $221.5M in net income for fiscal year 2025 (5.1% net margin).
Dividend & Returns
Yes, CNO Financial Group, Inc. (CNO) pays a dividend with a yield of 1.33%. This makes it attractive for income-focused investors.
CNO Financial Group, Inc. (CNO) has a return on equity (ROE) of 8.9%. This is below average, suggesting room for improvement.
Industry Metrics
CNO Financial Group, Inc. (CNO) has a combined ratio of 93.5%. A ratio below 100% indicates underwriting profitability.